Overnight Digest- Stocks to look out for on April 28

DSIJ Intelligence / 27 Apr 2017

Overnight Digest- Stocks to look out for on April 28

The stocks which are expected to witness significant movement on April 28 are Kolte-Patil Developers, IDFC/CEAT, Maruti Suzuki India, Reliance Industries and Fortis Healthcare.

The stocks which are expected to witness significant movement on April 28 are Kolte-Patil Developers, IDFC/CEAT, Maruti Suzuki India, Reliance Industries and Fortis Healthcare.

Kolte-Patil Developers: Kolte-Patil Developers has signed agreement for a redevelopment project in Mumbai. The share price of the company will remain in the limelight on Friday.

IDFC/CEAT: IDFC and CEAT will declare their Q4FY17 results on Friday. The share prices of these companies will be in focus on April 28.

Maruti Suzuki India: Maruti Suzuki India’s Q4FY17 profit jumped 16 per cent to Rs 1709 crore. The share price of the company will remain in the limelight on Friday.

Reliance Industries: Telecom regulator TRAI plans to start by May industry-wide consultation on framing rules for new mobile operators testing their services prior to full-fledged commercial launch. The share price of the company will be watched on April 28.

Fortis Healthcare: Fortis Healthcare’s three hospitals recycled one-use angio medical devices as per FDA. The share price of the company will remain in the limelight on Friday.

If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.